Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Sequential therapy involving an early switch from entecavir to pegylated interferon-α in Japanese patients with chronic hepatitis B

Published:2018-02-12 Issue:6 Volume:48 Page:459-468
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Enomoto Masaru¹,Nishiguchi Shuhei²,Tamori Akihiro¹,Kozuka Ritsuzo¹,Fujii Hideki¹,Uchida-Kobayashi Sawako¹,Fukunishi Shinya³,Tsuda Yasuhiro³,Higuchi Kazuhide³,Saito Masaki²,Enomoto Hirayuki²,Kawada Norifumi¹

Affiliation:

1. Department of Hepatology; Osaka City University Medical School; Osaka Japan

2. Department of Internal Medicine; Hyogo College of Medicine; Nishinomiya Japan

3. Second Department of Internal Medicine; Osaka Medical College; Osaka Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.13050/fullpdf

Reference51 articles.

1. Hepatitis B virus infection;Trépo;Lancet,2014

2. AASLD guidelines for treatment of chronic hepatitis B;Terrault;Hepatology,2016

3. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection;European Association for the Study of the Liver;J Hepatol,2017

4. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update;Sarin;Hepatol Int,2016

5. JSH guidelines for the management of hepatitis B virus infection;Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology;Hepatol Res,2014

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Survey of Different Treatment Methods for Chronic Viral Hepatitis B;Advances in Clinical Medicine;2023

2. Reduction of Hepatitis B Surface Antigen May Be More Significant in PEGylated Interferon-Alpha Therapy Combined with Nucleotide Analogues than Combined with Nucleoside Analogues in Chronic Hepatitis B Patients: A Propensity Score Matching Study;Canadian Journal of Gastroenterology and Hepatology;2022-12-07

3. Combined effects of tenofovir and interferon α1b on viral load and levels of peripheral regulatory T cells in chronic hepatitis B subjects;Tropical Journal of Pharmaceutical Research;2021-05-24

4. Combination of Entecavir or Tenofovir with Pegylated Interferon-α for Long-Term Reduction in Hepatitis B Surface Antigen Levels: Simultaneous, Sequential, or Add-on Combination Therapy;International Journal of Molecular Sciences;2021-02-01

5. Possible Relevance of PNPLA3 and TLL1 Gene Polymorphisms to the Efficacy of PEG-IFN Therapy for HBV-Infected Patients;International Journal of Molecular Sciences;2020-04-27